Barclays’s Universal Health Services UHS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-48,000
| Closed | -$6.22M | – | 5635 |
|
|
2021
Q4 | $6.22M | Buy |
+48,000
| New | +$6.17M | ﹤0.01% | 1557 |
|
|
2020
Q2 | – | Sell |
-1,000
| Closed | -$99K | – | 6262 |
|
|
2020
Q1 | $99K | Buy |
1,000
+500
| +100% | +$63.3K | ﹤0.01% | 4810 |
|
|
2019
Q4 | $72K | Buy |
+500
| New | +$71.3K | ﹤0.01% | 5624 |
|
|
2019
Q2 | – | Sell |
-2,300
| Closed | -$308K | – | 7288 |
|
|
2019
Q1 | $308K | Buy |
2,300
+900
| +64% | +$118K | ﹤0.01% | 4512 |
|
|
2018
Q4 | $163K | Hold |
1,400
| – | – | ﹤0.01% | 4720 |
|
|
2018
Q3 | $179K | Sell |
1,400
-500
| -26% | -$61.4K | ﹤0.01% | 5099 |
|
|
2018
Q2 | $212K | Buy |
1,900
+100
| +6% | +$11.7K | ﹤0.01% | 4677 |
|
|
2018
Q1 | $213K | Sell |
1,800
-900
| -33% | -$107K | ﹤0.01% | 4781 |
|
|
2017
Q4 | $306K | Sell |
2,700
-14,300
| -84% | -$1.53M | ﹤0.01% | 4327 |
|
|
2017
Q3 | $1.89M | Sell |
17,000
-5,900
| -26% | -$664K | ﹤0.01% | 2416 |
|
|
2017
Q2 | $2.8M | Buy |
22,900
+22,200
| +3,171% | +$2.64M | ﹤0.01% | 1958 |
|
|
2017
Q1 | $87K | Buy |
700
+500
| +250% | +$59.1K | ﹤0.01% | 4983 |
|
|
2016
Q4 | $21K | Sell |
200
-1,400
| -88% | -$166K | ﹤0.01% | 5604 |
|
|
2016
Q3 | $197K | Buy |
1,600
+400
| +33% | +$50.7K | ﹤0.01% | 3983 |
|
|
2016
Q2 | $161K | Sell |
1,200
-4,600
| -79% | -$607K | ﹤0.01% | 4085 |
|
|
2016
Q1 | $719K | Buy |
5,800
+3,200
| +123% | +$360K | ﹤0.01% | 2823 |
|
|
2015
Q4 | $309K | Sell |
2,600
-3,200
| -55% | -$391K | ﹤0.01% | 3562 |
|
|
2015
Q3 | $719K | Sell |
5,800
-10,800
| -65% | -$1.5M | ﹤0.01% | 3033 |
|
|
2015
Q2 | $2.36M | Buy |
16,600
+8,300
| +100% | +$1.04M | ﹤0.01% | 2107 |
|
|
2015
Q1 | $971K | Sell |
8,300
-26,000
| -76% | -$2.88M | ﹤0.01% | 3007 |
|
|
2014
Q4 | $3.81M | Buy |
34,300
+31,300
| +1,043% | +$3.29M | ﹤0.01% | 1934 |
|
|
2014
Q3 | $312K | Sell |
3,000
-2,900
| -49% | -$308K | ﹤0.01% | 4368 |
|
|
2014
Q2 | $561K | Buy |
5,900
+4,200
| +247% | +$363K | ﹤0.01% | 3862 |
|
|
2014
Q1 | $139K | Sell |
1,700
-163,600
| -99% | -$13.2M | ﹤0.01% | 5145 |
|
|
2013
Q4 | $13.4M | Sell |
165,300
-3,100
| -2% | -$248K | 0.01% | 1038 |
|
|
2013
Q3 | $12.5M | Buy |
168,400
+92,900
| +123% | +$6.48M | 0.01% | 984 |
|
|
2013
Q2 | $5.06M | Buy |
+75,500
| New | +$4.99M | 0.01% | 1619 |
|
Other funds holding UHS
Barclays's UHS Position: Q3 2026 in Review
Barclays reduced its Universal Health Services (UHS) stake by 16% in Q3 2026, selling an estimated $4.88M and leaving 157,542 shares worth $27.5M. The position accounts for 0.01% of the portfolio, ranked #1076.
Barclays first reported a position in UHS in Q2 2013 and has held it in 54 quarters since. The position peaked at $43.2M in Q3 2024. 518 funds tracked by Wall St. Rank hold UHS as of Q3 2026.
- Barclays held 157,542 shares of Universal Health Services worth $27.5M as of Q3 2026.
- Barclays sold 29,144 Universal Health Services shares in Q3 2026, an estimated $4.88M.
- Universal Health Services made up 0.01% of Barclays's portfolio in Q3 2026, its #1076 holding.
- Barclays first reported a position in Universal Health Services in Q2 2013 and has held it in 54 quarters since.
- Barclays's Universal Health Services position peaked at $43.2M in Q3 2024.
- 518 funds tracked by Wall St. Rank held Universal Health Services as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.